Medicana Health Group, a globally recognised leader in integrated healthcare services, is set to venture into the UK, aiming to fulfil the increasing demand for exceptional healthcare solutions.
Known for its exemplary integrated healthcare services, Medicana Health Group is on the brink of expanding its reach to the UK, showcasing its renowned patient-centric methodology and individualised care regimes. This strategic move is geared towards accommodating the escalating pursuit of private healthcare and insurance in the aftermath of the COVID pandemic. Medicana’s foundational commitment to “active listening and personalised attention” underpins its approach to understand and meet the distinct needs of each patient, promising a healthcare journey that is bespoke from the onset of consultation to the continuum of aftercare, aiming to innovate the paradigm of private healthcare in the UK.
By embedding “active listening and personalised attention at every stage of the patient’s journey,” Medicana Health Group aims to furnish an experience that is intimately customised and diligently conceived, replicating their triumphant model in Türkiye to instigate a transformative shift in private healthcare within the UK.
Embarking on the £282 Billion UK Healthcare Market
The rejuvenation of the UK’s private healthcare sector, especially post-COVID, has been markedly influenced by a surge in self-financing patients. An ever-increasing populace is now opting for private healthcare avenues to circumvent the prolonged waiting durations synonymous with the NHS, seeking the high-quality services and expertise of the independent sector. As per the Akeso report, the UK’s healthcare expenditure for the year 2022 was pegged at around £282 billion, with public (government) funding comprising approximately 80% and private (non-government) investments accounting for about 20%.
In this expanding market landscape, Medicana aspires to utilise its extensive expertise and a broad spectrum of care services to make significant inroads into the UK’s private healthcare sector. Introducing its tested and proven model of care, which encompasses a range from comprehensive diagnostics to custom-tailored treatments, Medicana is poised to cater to the growing appetite for premier private healthcare. The group’s resolute pursuit of excellence, coupled with its progressive approach to patient management, earmarks Medicana as a befitting response to the UK’s healthcare quandaries.
Servicing Over 5.5 Million Patients Annually
Every year, Medicana Health Group extends its top-tier healthcare services to more than 5.5 million patients worldwide, facilitated through its network of 16 hospitals that feature extensive bed capacities. This not only reflects their expansive experience in delivering superior healthcare but also their capability to navigate the intricate requirements of a global patient audience. The introduction of Medicana Health Group into the UK market is poised to usher in a substantial evolution towards more empathetic, efficient, and personalised healthcare solutions, heralding a significant epoch in their ongoing crusade to uplift patient care and elevate healthcare standards across the globe.
With an illustrious lineage spanning over 30 years, Medicana’s expertise traverses a vast array of medical specialities, delivering forefront services in realms such as Oncology, Surgical Oncology, Organ and Bone Marrow Transplantation, Neurosurgery, In Vitro Fertilisation (IVF), Genetics, Cardiovascular Surgery, Orthopaedics and Traumatology, and Obesity Surgery. Since 2016, Medicana Health Group has further broadened its horizons into the educational domain, providing an extensive gamut of educational programs from the preschool level to university education, both within Türkiye and internationally.
